Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

Worldwide, hepatitis C virus (HCV) is a common infection. Due to new antiviral approaches and the approval of direct-acting antiviral agents (DAA), HCV therapy has become more comfortable. Nevertheless, there are special patient groups, in whom treatment of HCV is still challenging. Due to only few...

Full description

Bibliographic Details
Main Authors: Anna Hüsing, Iyad Kabar, Hartmut H. Schmidt, Hauke S. Heinzow
Format: Article
Language:English
Published: MDPI AG 2015-08-01
Series:International Journal of Molecular Sciences
Subjects:
HCV infection
chronic kidney disease
renal transplantation
decompensated liver cirrhosis
liver transplantation
new therapy regimen
DAA treatment
Online Access:http://www.mdpi.com/1422-0067/16/8/18033

Internet

http://www.mdpi.com/1422-0067/16/8/18033

Similar Items